| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Across the last three months, Immunovant, Inc.'s insiders have reduced their positions by a net 110,922 shares worth roughly $4.2M. In the past 30 days, 0 insiders bought and 3 sold.
On the other side, 3 insiders reduced their position over the period. IMVT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 240.8K | $9.86M | -6,798 | |
| COO | 222.5K | $9.11M | - | |
| Other | 218.0K | $8.92M | - | |
| Other | 205.3K | $8.40M | -2,857 | |
| Other | 179.4K | $7.34M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2025 | MacIas William L.51 | Chief Medical Officer | Sell | 2,383 | $23.83 | $56,782.17 | -0.2% | -36.6% | +6.6% | |
| Jan 15, 2025 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 2,298 | $23.83 | $54,756.80 | -0.4% | -36.6% | +6.6% | |
| Jan 15, 2025 | Salzmann Peter51 | Chief Executive Officer | Sell | 8,767 | $23.83 | $208,899.97 | -0.5% | -36.6% | +6.6% | |
| Jan 8, 2025 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 4,105 | $24.10 | $98,930.50 | -1.2% | -43.7% | +11.3% | |
| Jan 8, 2025 | Salzmann Peter51 | Chief Executive Officer | Sell | 5,105 | $24.10 | $123,030.50 | -0.5% | -43.7% | +11.3% | |
| Dec 2, 2024 | Hughes Douglas J. | Director | Sell | 5,425 | $28.54 | $154,829.50 | -4.3% | -35.9% | -23.5% | |
| Dec 2, 2024 | Pande Atul74 | Director | Sell | 7,750 | $28.54 | $221,185.00 | -8.2% | -35.9% | -23.5% | |
| Nov 20, 2024 | Levine Mark S.66 | Chief Legal Officer | Sell | 3,650 | $25.45 | $92,892.50 | -1.1% | -20.4% | -12.9% | |
| Nov 20, 2024 | MacIas William L.51 | Chief Medical Officer | Sell | 3,353 | $25.45 | $85,333.85 | -0.9% | -20.4% | -12.9% | |
| Nov 20, 2024 | Barnett Eva Renee58 | Chief Financial Officer | Sell | 4,174 | $25.45 | $106,228.30 | -1.2% | -20.4% | -12.9% |